Nurse Practitioner · Boston, MA
NPI
1992348502
Since 2019
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
800 Washington St # 70
Boston, MA, 02111
Phone (617) 636-3299
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$353K
452 prescriptions
Company payments, 2023
$80.32
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Paula J Mooney prescribed most often to Medicare patients was Metoprolol Succinate, with 91 prescriptions and refills. In total Paula J Mooney wrote 452 Medicare prescriptions that cost $353K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Metoprolol Succinate Generic | 91 | 214 | 35 | $1,746 |
| Eliquis Apixaban | 63 | 105 | 14 | $58K |
| Verapamil Er Verapamil Hcl | 42 | 106 | 14 | $1,203 |
| Amlodipine Besylate Generic | 34 | 84 | 11 | $212 |
| Camzyos Mavacamten | 30 | 31 | Under 11 | $258K |
| Norpace Cr Disopyramide Phosphate | 23 | 31 | Under 11 | $9,238 |
| Hydrochlorothiazide Generic | 21 | 46 | Under 11 | $33.36 |
| Metoprolol Tartrate Generic | 14 | 40 | Under 11 | $83.35 |
| Jardiance Empagliflozin | 14 | 20 | Under 11 | $12K |
| Spironolactone Generic | 13 | 23 | Under 11 | $101 |
| Furosemide Generic | 11 | 33 | Under 11 | $133 |
| Lisinopril Generic | 11 | 21 | Under 11 | $59.58 |
Brand drugs: 141 claims; generic drugs: 311 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Paula J Mooney $80.32 ($80.32 in general payments such as food, travel and fees) from 1 company. The largest payer was E.R. Squibb & Sons, L.L.C. with $80.32.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $80.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.